Lloyd Knapp

2.5k total citations
36 papers, 1.9k citations indexed

About

Lloyd Knapp is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lloyd Knapp has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 13 papers in Pediatrics, Perinatology and Child Health and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lloyd Knapp's work include Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Neuroscience and Neuropharmacology Research (8 papers). Lloyd Knapp is often cited by papers focused on Epilepsy research and treatment (14 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Neuroscience and Neuropharmacology Research (8 papers). Lloyd Knapp collaborates with scholars based in United States, Australia and Germany. Lloyd Knapp's co-authors include Alan R. Kugler, Elizabeth A. Garofalo, Howard N. Bockbrader, Linda LaMoreaux, Russell K. Portenoy, Ralph Richter, Uma Sharma, Jacqueline A. French, Jeffrey Miceli and Sarah Dubrava and has published in prestigious journals such as New England Journal of Medicine, Neurology and The Lancet Neurology.

In The Last Decade

Lloyd Knapp

35 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lloyd Knapp United States 20 770 644 592 582 391 36 1.9k
Ed Whalen United States 18 649 0.8× 163 0.3× 958 1.6× 494 0.8× 299 0.8× 59 2.0k
L. LaMoreaux United States 5 280 0.4× 244 0.4× 752 1.3× 438 0.8× 157 0.4× 11 1.4k
Luigi Maria Specchio Italy 26 1.7k 2.2× 1.2k 1.9× 208 0.4× 350 0.6× 249 0.6× 71 2.4k
Mark Versavel United States 13 301 0.4× 135 0.2× 691 1.2× 422 0.7× 154 0.4× 21 1.2k
Richard C. Risser United States 31 2.6k 3.4× 465 0.7× 372 0.6× 286 0.5× 107 0.3× 48 4.2k
Uma Sharma United States 16 1.1k 1.4× 169 0.3× 1.2k 2.1× 642 1.1× 607 1.6× 25 2.7k
Charles Chabal United States 22 336 0.4× 202 0.3× 819 1.4× 535 0.9× 140 0.4× 53 2.0k
Rafael Gálvez Spain 21 224 0.3× 232 0.4× 840 1.4× 364 0.6× 224 0.6× 67 1.6k
R. Di Perri Italy 24 786 1.0× 550 0.9× 129 0.2× 615 1.1× 201 0.5× 72 1.9k
Amy S. Chappell United States 26 995 1.3× 149 0.2× 1.0k 1.7× 363 0.6× 542 1.4× 52 2.7k

Countries citing papers authored by Lloyd Knapp

Since Specialization
Citations

This map shows the geographic impact of Lloyd Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lloyd Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lloyd Knapp more than expected).

Fields of papers citing papers by Lloyd Knapp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lloyd Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lloyd Knapp. The network helps show where Lloyd Knapp may publish in the future.

Co-authorship network of co-authors of Lloyd Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of Lloyd Knapp. A scholar is included among the top collaborators of Lloyd Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lloyd Knapp. Lloyd Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parsons, Bruce, et al.. (2019). <p>The relationship between the reporting of euphoria events and early treatment responses to pregabalin: an exploratory post-hoc analysis</p>. Journal of Pain Research. Volume 12. 2577–2587. 4 indexed citations
2.
Markman, John D., Malca Resnick, Nathaniel P. Katz, et al.. (2018). Efficacy of pregabalin in post-traumatic peripheral neuropathic pain: a randomized, double-blind, placebo-controlled phase 3 trial. Journal of Neurology. 265(12). 2815–2824. 21 indexed citations
3.
Parsons, Bruce, et al.. (2017). (411) Relationship between euphoria and early treatment response to pregabalin in patients with chronic pain. Journal of Pain. 18(4). S77–S77. 1 indexed citations
4.
Chelly, Jacques E., David R. Lionberger, Joseph Gimbel, et al.. (2014). Pregabalin for the treatment of postoperative pain: results from three controlled trials using different surgical models. Journal of Pain Research. 8. 9–9. 41 indexed citations
5.
Allen, Richard P., Diego García‐Borreguero, Olli Polo, et al.. (2014). Comparison of Pregabalin with Pramipexole for Restless Legs Syndrome. New England Journal of Medicine. 370(7). 621–631. 152 indexed citations
6.
Parsons, Bruce, Birol Emir, & Lloyd Knapp. (2014). Examining the Time to Improvement of Sleep Interference With Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy and Postherpetic Neuralgia. American Journal of Therapeutics. 22(4). 257–268. 15 indexed citations
7.
Kasper, Siegfried, Celso Iglesias García, Edward E. Schweizer, et al.. (2013). Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder. The International Journal of Neuropsychopharmacology. 17(5). 685–695. 25 indexed citations
8.
Rickels, Karl, et al.. (2012). Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment. International Clinical Psychopharmacology. 27(3). 142–150. 44 indexed citations
9.
Parsons, Bruce, Birol Emir, & Lloyd Knapp. (2012). Examining the time-to-improvement of sleep disturbance in patients with painful diabetic peripheral neuropathy and post-herpetic neuralgia. Journal of Pain. 13(4). S63–S63. 2 indexed citations
10.
Bockbrader, Howard N., Paula Burger, Lloyd Knapp, & Brian Corrigan. (2011). Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures. Epilepsia. 52(2). 248–257. 33 indexed citations
11.
Kwan, Patrick, Martin J. Brodie, Reetta Kälviäinen, et al.. (2011). Efficacy and safety of pregabalin versus lamotrigine in patients with newly diagnosed partial seizures: a phase 3, double-blind, randomised, parallel-group trial. The Lancet Neurology. 10(10). 881–890. 67 indexed citations
12.
Bockbrader, Howard N., Paula Burger, & Lloyd Knapp. (2010). Pregabalin effect on steady‐state pharmacokinetics of carbamazepine, lamotrigine, phenobarbital, phenytoin, topiramate, valproate, and tiagabine. Epilepsia. 52(2). 405–409. 19 indexed citations
13.
Allen, Richard P., Adina Soaita, Lloyd Knapp, et al.. (2010). A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome. Sleep Medicine. 11(6). 512–519. 68 indexed citations
14.
Knapp, Lloyd, et al.. (2009). The safety profile of quinapril: Is there a difference among ACE inhibitors?. Clinical Cardiology. 13(S7). VII–39. 1 indexed citations
15.
Miceli, J., et al.. (2009). P.4.a.015 Adjunctive pregabalin after partial response to SSRI or SNRI in GAD: results of a double-blind, placebo-controlled trial. European Neuropsychopharmacology. 19. S593–S594. 1 indexed citations
16.
Richter, Ralph, Russell K. Portenoy, Uma Sharma, et al.. (2005). Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial. Journal of Pain. 6(4). 253–260. 370 indexed citations
17.
18.
Ramsay, R. Eugene, B. J. Wilder, Basim M. Uthman, et al.. (1997). Intramuscular fosphenytoin (Cerebyx®) in patients requiring a loading dose of phenytoin. Epilepsy Research. 28(3). 181–187. 28 indexed citations
19.
Knapp, Lloyd, et al.. (1990). The Safety and Tolerability of Quinapril. Journal of Cardiovascular Pharmacology. 15. S47–S55. 14 indexed citations
20.
Knapp, Lloyd, et al.. (1990). Overview of Quinapril, A New ACE Inhibitor. Journal of Cardiovascular Pharmacology. 15. S14–S23. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ed Whalen Breakdown of academic impact, for papers by L. LaMoreaux Breakdown of academic impact, for papers by Luigi Maria Specchio Breakdown of academic impact, for papers by Mark Versavel Breakdown of academic impact, for papers by Richard C. Risser Breakdown of academic impact, for papers by Uma Sharma Breakdown of academic impact, for papers by Charles Chabal Breakdown of academic impact, for papers by Rafael Gálvez Breakdown of academic impact, for papers by R. Di Perri Breakdown of academic impact, for papers by Amy S. Chappell
Rankless by CCL
2026